EGFR mutation testing in non-small cell lung cancer (NSCLC)

EGFR mutation testing in non-small cell lung cancer (NSCLC)

Summary: Lung carcinoma is subdivided into small cell carcinoma and non-small cell carcinoma (NSCLC). NSCLC is heterogeneous group of carcinomas and accounts for 70–80% of lung cancer. NSCLC is further divided into adenocarcinoma, squamous cell carcinoma, and large cell carcinoma.Activating somatic...

Full description

Bibliographic Details
Main Author:	Fouad Al Dayel
Format:	Article
Language:	English
Published:	Elsevier 2012-12-01
Series:	Journal of Infection and Public Health
Online Access:	http://www.sciencedirect.com/science/article/pii/S1876034112001190

Similar Items

Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)
by: Connor O’Leary, et al.
Published: (2020-09-01)

The Presence of Concomitant Mutations Affects the Activity of EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Patients
by: Anna Maria Rachiglio, et al.
Published: (2019-03-01)

Navigating the “No Man's Land” of TKI-Failed EGFR-Mutated Non–Small Cell Lung Cancer (NSCLC): A Review
by: Bryan Oronsky, et al.
Published: (2018-01-01)

Detection of EGFR Mutations in cfDNA and CTCs, and Comparison to Tumor Tissue in Non-Small-Cell-Lung-Cancer (NSCLC) Patients
by: Haiyan E. Liu, et al.
Published: (2020-10-01)

Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC)
by: Petr Makhov, et al.
Published: (2021-03-01)

Japanese Lung Cancer Society Guidelines for Stage IV NSCLC With EGFR Mutations
by: Kiichiro Ninomiya, MD, PhD, et al.
Published: (2021-01-01)

Role of the dynamic tumor microenvironment in controversies regarding immune checkpoint inhibitors for the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations
by: Anqi Lin, et al.
Published: (2019-09-01)

Brain metastasis in non-small cell lung cancer (NSCLC) patients with uncommon EGFR mutations: a report of seven cases and literature review
by: Puchun Er, et al.
Published: (2017-08-01)

Accurate Classification of Non-small Cell Lung Cancer (NSCLC) Pathology and Mapping of EGFR Mutation Spatial Distribution by Ambient Mass Spectrometry Imaging
by: Min Zhang, et al.
Published: (2019-08-01)

Detecting EGFR mutations in patients with non-small cell lung cancer
by: Hammoudeh ZA, et al.
Published: (2018-10-01)

Characterisation of EGFR and KRAS mutations in non-small cell lung cancer
by: Martinsson, Caroline
Published: (2010)

The Detection Methods of EGFR Mutations in Non-small Cell Lung Cancer
by: Xinyu ZHANG, et al.
Published: (2011-03-01)

Distribution of EGFR Mutations in Patients with Non-small Cell Lung Cancer.
by: LIN,YEN-HSIU, et al.
Published: (2017)

EGFR T790M mutation after chemotherapy for small cell lung cancer transformation of EGFR-positive non-small cell lung cancer
by: Tomoaki Sonoda, et al.
Published: (2018-01-01)

Immunohistochemical Detections of EGFR Mutations in NSCLC
by: Chang LIU, et al.
Published: (2014-09-01)

Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non‐small cell lung cancer
by: Azhar Ali, et al.
Published: (2018-03-01)

A Review of EGFR-TKIs Therapy of Non-small Cell Lung Cancer with Uncommon EGFR Mutations
by: Wenxing DU, et al.
Published: (2019-09-01)

Polymorphisms, mutations, and amplification of the EGFR gene in non-small cell lung cancers.
by: Masaharu Nomura, et al.
Published: (2007-04-01)

Clinical and surgical implications of EGFR mutations in non-small cell lung cancer
by: M. Yoon, et al.
Published: (2016-08-01)

Lysine acetyltransferase 5 in EGFR mutated non-small cell lung cancer
by: Pan, Gilbert
Published: (2018)

Clinical Features of EGFR Double Mutation in Non-small Cell Lung Cancer
by: Mengyao WANG, et al.
Published: (2018-08-01)

Progress in Non-invasive Detection of EGFR Mutation in Non-small Cell Lung Cancer
by: Shiyang YUAN, et al.
Published: (2018-12-01)

A Multi-Center, Real-Life Experience on Liquid Biopsy Practice for EGFR Testing in Non-Small Cell Lung Cancer (NSCLC) Patients
by: Francesco Cortiula, et al.
Published: (2020-09-01)

Poor Prognosis With Coexistence Of EGFR T790M Mutation And Common EGFR-Activating Mutation In Non- Small Cell Lung Cancer
by: Gao X, et al.
Published: (2019-11-01)

EGFR plasma mutation in prediction models for resistance with EGFR TKI and survival of non-small cell lung cancer
by: Thang Thanh Phan, et al.
Published: (2019-01-01)

The effectiveness of EGFR-TKIs against brain metastases in EGFR mutation-positive non-small-cell lung cancer
by: Bai H, et al.
Published: (2017-04-01)

Prognostic Factors in Non-Small Cell Lung Cancer (NSCLC)
by: Holgersson, Georg
Published: (2017)

Molecular Status of EGFR and KRAS Predicts Response to Erlotinib in Non-Small Cell Lung Cancer (NSCLC): a Meta-Analysis
by: Bao-ju Chen, et al.
Published: (2010)

Molecular Status of EGFR and KRAS Predicting Response to Erlotinib in Non-Small Cell Lung Cancer (NSCLC): a Meta-Analysis
by: Bao-Ju Chen, et al.
Published: (2010)

Plasma Predictive Features in Treating EGFR-Mutated Non-Small Cell Lung Cancer
by: Christi M. J. Steendam, et al.
Published: (2020-10-01)

EGFR mutations as a prognostic and predictive marker in non-small-cell lung cancer
by: Fang S, et al.
Published: (2014-09-01)

Tyrosine kinase inhibitors for EGFR- and ALK-mutated non-small cell lung cancer
by: Jonathan R. Thompson, et al.
Published: (2016-10-01)

Research Progress of EGFR T790M Mutation in Non-small Cell Lung Cancer
by: HOU Ran, et al.
Published: (2020-06-01)

Molecular Imaging in vivo Detection of EGFR Mutations in Non-small Cell Lung Cancer
by: Danjing LUO, et al.
Published: (2017-06-01)

Advances in Double Mutations of EGFR and ALK Gene in Non-small Cell Lung Cancer
by: Xin WANG, et al.
Published: (2018-09-01)

Novel therapeutic strategies for targeting EGFR mutated non-small cell lung cancer
by: Drobnitzky, Neele
Published: (2017)

Chinese Medicine Combined With EGFR-TKIs Prolongs Progression-Free Survival and Overall Survival of Non-small Cell Lung Cancer (NSCLC) Patients Harboring EGFR Mutations, Compared With the Use of TKIs Alone
by: Yujia Wang, et al.
Published: (2021-06-01)

Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer
by: Viteri Santiago, et al.
Published: (2010-12-01)

Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using real-life data
by: Lourdes Gutiérrez, et al.
Published: (2021-08-01)

Genomic Characterization of Concurrent Alterations in Non-Small Cell Lung Cancer (NSCLC) Harboring Actionable Mutations
by: Antonio Passaro, et al.
Published: (2021-04-01)